Cannabis evidence for Inflammation

Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Cannabis and cannabinoid research · 2021

RCT n=321

Oral CBD-rich Cannabis Induces Clinical but Not Endoscopic Response in Patients with Crohn’s Disease, a Randomised Controlled Trial.

Journal of Crohn's & colitis · 2021

RCT n=56

Impact of cannabidiol on myocardial recovery in patients with acute myocarditis: primary results of the ARCHER study.

ESC heart failure · 2026

RCT n=109

Cannabis for the treatment of Crohn’s disease.

The Cochrane database of systematic reviews · 2018

Systematic Review n=50

Cannabis for the treatment of ulcerative colitis.

The Cochrane database of systematic reviews · 2018

Systematic Review n=60

The Pleiotropic Influence of Cannabidiol and Tetrahydrocannabinol on Inflammatory Biomarkers: A Systematic Review and Meta-Analytical Synthesis.

International journal of molecular sciences · 2025

Meta-analysis of the Therapeutic Impact of Cannabinoids in Inflammatory Bowel Disease.

Inflammatory bowel diseases · 2025

Self-Reported Cannabis Use and Markers of Inflammation in Men Who Have Sex With Men With and Without HIV.

Cannabis and cannabinoid research · 2021

n=1,352

The Effect of Cannabis-Based Medicine in the Treatment of Cachexia: A Systematic Review and Meta-Analysis.

Cannabis and cannabinoid research · 2021

Association between chronic psychoactive substances use and systemic inflammation: A systematic review and meta-analysis.

Neuroscience and biobehavioral reviews · 2021

A Systematic Review With Meta-Analysis of the Efficacy of Cannabis and Cannabinoids for Inflammatory Bowel Disease: What Can We Learn From Randomized and Nonrandomized Studies?

Journal of clinical gastroenterology · 2021

Cannabis use in Crohn’s disease: a systematic review and meta-analysis of randomized controlled trials (RCTs).

Irish journal of medical science · 2025

Thromboembolic Outcomes in Tetrahydrocannabinol-Positive Trauma Patients With Traumatic Brain Injury.

The Journal of surgical research · 2022

n=13,266

Therapeutic Potential for Cannabidiol on Alzheimer’s Disease-Related Neuroinflammation: A Systematic Review and Meta-Analysis.

International journal of molecular sciences · 2025

Does a broad-spectrum cannabidiol supplement improve performance in a 10-min cycle ergometer performance-test?

European journal of sport science · 2024

RCT n=11

The concomitant use of cannabis and cocaine coexists with increased LPS levels and systemic inflammation in male drug users.

Cytokine · 2021

RCT n=27

The effect of a mixed cannabidiol and cannabidiolic acid based oil on client-owned dogs with atopic dermatitis.

Veterinary dermatology · 2022

RCT n=17

Cannabis is associated with clinical but not endoscopic remission in ulcerative colitis: A randomized controlled trial.

PloS one · 2021

RCT n=32

Efficacy and safety of cannabidiol oil in psoriasis: a randomized, double-blind, placebo-controlled trial.

The Journal of dermatological treatment · 2025

RCT n=28

Therapeutic Potential of Cannabidiol in Dentistry: A Systematic Review From Cellular Mechanisms to Clinical Trials.

Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology · 2025

Efficacy and safety of cannabidiol for the treatment of canine osteoarthritis: a systematic review and meta-analysis of animal intervention studies.

Frontiers in veterinary science · 2023

[Cannabis use among patients with inflammatory bowel disease].

Orvosi hetilap · 2021

Evaluating efficacy, safety, and innovation in skin care applications of essential oils: a systematic review.

Frontiers in medicine · 2025

Efficacy of minocycline in substance use disorder: A systematic review of preclinical and clinical studies.

Pharmacology, biochemistry, and behavior · 2025